RxDoctor Payments Data

Suzanne Girard, NP

Nurse Practitioner · Kenosha, WINPI 1578196770

Payments from drug & device makers

$1,063in general payments, 2019–2025

Across 45 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$257
  • Johnson & Johnson$147
  • AbbVie$120
  • Alkermes, Inc.$79
  • Teva Pharmaceuticals USA, Inc.$69
  • Neurocrine Biosciences, Inc.$66
  • plus $326 from 11 others

What the payments were for

  • Food & beverage$90885%
  • Education$15515%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,063 in reported general payments places this provider in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$7,531
Medicare patients
98
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide62$79,273
JardianceEmpagliflozin32$28,347
Albuterol Sulfate HfaAlbuterol Sulfate151$2,902
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,834
Wixela InhubFluticasone Propion/Salmeterol16$1,940
Omeprazole129$1,512
Levothyroxine Sodium64$1,484
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,280
Ventolin HfaAlbuterol Sulfate21$1,273
Gabapentin50$1,111
FenofibrateFenofibrate Nanocrystallized28$1,099
Fluticasone Propionate50$1,022
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine33$983
Atorvastatin Calcium144$919
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$844

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$17$79,27362 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →